BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33675293)

  • 1. Low level of stromal lectin-like oxidized LDL receptor 1 and CD8
    Katayama C; Yokobori T; Ozawa N; Suga K; Shiraishi T; Okada T; Osone K; Katoh R; Suto T; Motegi Y; Ogawa H; Sano A; Sakai M; Sohda M; Erkhem-Ochir B; Gombodorj N; Katayama A; Oyama T; Shirabe K; Kuwano H; Saeki H
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1364. PubMed ID: 33675293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.
    Kim Y; Wen X; Bae JM; Kim JH; Cho NY; Kang GH
    Histopathology; 2018 Oct; 73(4):663-671. PubMed ID: 29906313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer.
    Song X; Xie D; Tan F; Zhou Y; Li Y; Zhou Z; Pei Q; Pei H
    Aging (Albany NY); 2021 Aug; 13(16):20609-20628. PubMed ID: 34438367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression.
    Lalos A; Tülek A; Tosti N; Mechera R; Wilhelm A; Soysal S; Daester S; Kancherla V; Weixler B; Spagnoli GC; Eppenberger-Castori S; Terracciano L; Piscuoglio S; von Flüe M; Posabella A; Droeser RA
    Sci Rep; 2021 Jan; 11(1):775. PubMed ID: 33436863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.
    Chen EP; Markosyan N; Connolly E; Lawson JA; Li X; Grant GR; Grosser T; FitzGerald GA; Smyth EM
    Carcinogenesis; 2014 Aug; 35(8):1788-97. PubMed ID: 24590894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
    Narayanan S; Kawaguchi T; Yan L; Peng X; Qi Q; Takabe K
    Ann Surg Oncol; 2018 Aug; 25(8):2323-2331. PubMed ID: 29770915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of LOX-1
    Li X; Li JL; Jiang N; Chen J; Liang ZM; Zhao ZL; Xing YF
    Aging (Albany NY); 2020 Dec; 13(1):437-449. PubMed ID: 33290259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Analysis of Immune Infiltrates in Primary Melanoma.
    Gartrell RD; Marks DK; Hart TD; Li G; Davari DR; Wu A; Blake Z; Lu Y; Askin KN; Monod A; Esancy CL; Stack EC; Jia DT; Armenta PM; Fu Y; Izaki D; Taback B; Rabadan R; Kaufman HL; Drake CG; Horst BA; Saenger YM
    Cancer Immunol Res; 2018 Apr; 6(4):481-493. PubMed ID: 29467127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral Cytotoxic T-Lymphocyte Density and PD-L1 Expression Are Prognostic Biomarkers for Patients with Colorectal Cancer.
    Calik I; Calik M; Turken G; Ozercan IH; Dagli AF; Artas G; Sarikaya B
    Medicina (Kaunas); 2019 Oct; 55(11):. PubMed ID: 31683723
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum LOX-1 is a novel prognostic biomarker of colorectal cancer.
    Nakashima-Nakasuga C; Hazama S; Suzuki N; Nakagami Y; Xu M; Yoshida S; Tomochika S; Fujiwara N; Matsukuma S; Matsui H; Tokumitsu Y; Kanekiyo S; Shindo Y; Maeda N; Tsunedomi R; Iida M; Takeda S; Yoshino S; Ueno T; Hamamoto Y; Ogihara H; Hoshii Y; Nagano H
    Int J Clin Oncol; 2020 Jul; 25(7):1308-1317. PubMed ID: 32277394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer.
    Murdocca M; Mango R; Pucci S; Biocca S; Testa B; Capuano R; Paolesse R; Sanchez M; Orlandi A; di Natale C; Novelli G; Sangiuolo F
    Oncotarget; 2016 Mar; 7(12):14765-80. PubMed ID: 26895376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoplasmic reticulum stress induced LOX-1
    Nan J; Xing YF; Hu B; Tang JX; Dong HM; He YM; Ruan DY; Ye QJ; Cai JR; Ma XK; Chen J; Cai XR; Lin ZX; Wu XY; Li X
    Immunology; 2018 May; 154(1):144-155. PubMed ID: 29211299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer.
    Shen Y; Guan Y; Hummel JJ; Shyu CR; Mitchem JB
    BMC Cancer; 2020 Feb; 20(1):124. PubMed ID: 32059711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized low-density lipoprotein stimulates CD206 positive macrophages upregulating CD44 and CD133 expression in colorectal cancer with high-fat diet.
    Zheng SM; Chen H; Sha WH; Chen XF; Yin JB; Zhu XB; Zheng ZW; Ma J
    World J Gastroenterol; 2022 Sep; 28(34):4993-5006. PubMed ID: 36160648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma.
    Ohnishi K; Komohara Y; Saito Y; Miyamoto Y; Watanabe M; Baba H; Takeya M
    Cancer Sci; 2013 Sep; 104(9):1237-44. PubMed ID: 23734742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials.
    Moretto R; Corallo S; Belfiore A; Rossini D; Boccaccino A; Lonardi S; Centonze G; Morano F; Germani MM; Loupakis F; Morelli L; Urbani L; Brich S; Marmorino F; Prisciandaro M; Aprile G; Fassan M; Cillo U; Cattaneo L; Fontanini G; De Braud F; Falcone A; Milione M; Pietrantonio F; Cremolini C
    Eur J Cancer; 2020 Aug; 135():78-88. PubMed ID: 32554314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.
    Ling A; Edin S; Wikberg ML; Öberg Å; Palmqvist R
    Br J Cancer; 2014 May; 110(10):2551-9. PubMed ID: 24675384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma.
    Gartrell-Corrado RD; Chen AX; Rizk EM; Marks DK; Bogardus MH; Hart TD; Silverman AM; Bayan CY; Finkel GG; Barker LW; Komatsubara KM; Carvajal RD; Horst BA; Chang R; Monod A; Rabadan R; Saenger YM
    Cancer Res; 2020 Mar; 80(5):1078-1087. PubMed ID: 31948941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated assessment of CD8
    Jiang D; Hveem TS; Glaire M; Church DN; Kerr DJ; Yang L; Danielsen HE
    EBioMedicine; 2021 Sep; 71():103547. PubMed ID: 34479131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.